KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DSNOS. The owner is based in FOSHAN.

RM 2511, BLDG 1, BLOCK 5, NANSHUN

FOSHAN , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DSNOS
DSNOS
Registered 2020

Trademark Classifications

KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD. have?

KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD. file in?

KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD.'s most well-known trademarks?

KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as DSNOS. These are among 1 currently registered trademark in the portfolio.

What is KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD.'s trademark registration success rate?

KESU YOUPIN (FOSHAN) HEALTH TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.